(TAP) downgraded at UBS to Neutral from Buy, UBS said. $45 price target. Lack of cost savings and difficult volume environment.
(TXN) downgraded at Kaufman to Hold, Kaufman Bros. said. $35 price target. Stock is already pricing in a bottoming of the business.
(UPL) downgraded at Global Hunter from Accumulate to Neutral, Global Hunter said. $36 price target. Company will be hurt by the mild winter.
(WDC) upgraded at Needham from Hold to Buy, Needham said. $41 price target. Company can take advantage of a unique supply/demand situation in the disk drive industry.
Winthrop Realty Trust
upgraded to buy at TheStreet Ratings.
downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Estimates also cut, because of lower realized revenue.
rated new Outperform at Baird. $12 price target. Company is a market leader and leveraged to secular growth drivers.
STOCK COMMENTS / EPS CHANGES
estimates, target boosted at Sterne Agee. Shares of AAPL now seen reaching $540, according to Sterne Agee. Estimates also upped, as the company's guidance could prove to be less conservative than usual. Buy rating.
target raised at Jefferies to $43, Jefferies said. Estimates also raised on strong reseller survey. Buy rating.
target raised at Oppenheimer to $84, Oppenheimer said. Asfotase Alfa is significant addition to future growth. Outperform rating.
Bank of Hawaii
numbers increased at Credit Suisse. BOH estimates were raised through 2014, Credit Suisse said. Company can is post increased capital deployment and earning asset growth. Neutral rating and new $47 price target.
numbers upped at Auriga. CSCO estimates were boosted through 2013, Auriga USA said. Company should benefit from improving product cycles and better enterprise demand. Buy rating and new $24 price target.
target raised at Oppenheimer to $21, Oppenheimer said. Industrial margins are reset. Outperform rating.
estimates, target cut at Credit Suisse. HAL estimates were reduced through 2013, Credit Suisse said. Company is likely to see lower domestic land-based sales. Outperform rating and new $54 price target.
Halliburton numbers adjusted at UBS. Shares of HAL now seen reaching $48, according to UBS. Estimates increased on encouraging international margins guidance. Buy rating.